TOBEMSTOMIG

UNII:	93NRF4S9HR
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	TOBEMSTOMIG
GSRS Full Record:	93NRF4S9HR i

2648839-43-2
Anti-PD1/Anti-LAG3 Bispecific Antibody RO7247669
Immunoglobulin G1 [151-glutamic acid,217-glutamic acid,236-alanine,237-alanine,331-glycine,351-cysteine,368-serine,370-alanine,409-valine], anti-(human lymphocyte activation gene-3 protein) (human-Oryctolagus cuniculus monoclonal LAG3-0414 γ1-chain), disulfide with [123-arginine,124-lysine] (human-Oryctolagus cuniculus monoclonal LAG3-0414 κ-chain), (230→222′),(233→225′),(353→350′)-tris(disulfide) with immunoglobulin [endo-112-serine,endo-113-serine,230-alanine,231-alanine,325-glycine,350-cysteine,362-tryptophan] anti-(human programmed cell death protein 1) (human-Mus musculus monoclonal PD1-0376 κ-chain V-J region) fusion protein with immunoglobulin G1 (human γ1-chain C region) disulfide with immunoglobulin anti-(human programmed cell death protein 1) (human-Mus musculus monoclonal PD1-0376 heavy chain V-D-J region) fusion protein with immunoglobulin (human κ-chain C region)
PD1-LAG3 (RO-7247669)
PD1-LAG3 BSAB (RO-7247669)
PD1/LAG3 (RO-7247669)
RG-6139
RG6139
RO-7247669
RO7247669
TOBEMSTOMIG [USAN]
Tobemstomig
Tobemstomig [WHO-DD]
immunoglobulin G1-kappa with crossed domains, anti-[Homo sapiens PDCD1 (programmed cell death 1, PD1, PD-1, CD279)] and anti-[Homo sapiens LAG3 (lymphocyte activating 3, lymphocyte-activation 3, CD223)], humanized monoclonal antibody, bispecific
tobemstomig [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TOBEMSTOMIG

Synonyms and Mappings

Resources